Literature DB >> 32168186

The Association of Increasing Hospice Use With Decreasing Hospital Mortality: An Analysis of the National Inpatient Sample.

Christa A Schorr1, Mark Angelo, Gaughan John, Krista LeCompte, R Phillip Dellinger.   

Abstract

EXECUTIVE
SUMMARY: Usage of hospice services for patients facing life-limiting illness has steadily increased. In these services, hospitals discharge patients to various hospice settings, including the inpatient model, where a patient may remain in the discharging hospital to receive hospice services. In this discharge practice, the patient is considered a hospital survivor and subsequent hospice death. The purpose of the study was to determine if the decline of in-hospital mortality for six common high-volume admission diagnoses could be attributed in part to an increase in discharges to a hospice setting for end-of-life care. In this retrospective study using the National Inpatient Sample database from 2007 to 2011, we identified patients ≥18 years for six acute and chronic diagnoses: heart failure, chronic obstructive pulmonary disease, acute myocardial infarction, acute myocardial infarction with cardiogenic shock, septic shock, and lung neoplasm (cancer). We categorized patients according to their hospital discharge disposition as hospice or in-hospital mortality. A total of 10,458,728 patients met our criteria, of which 2.72% were discharged to hospice and 6.38% died. Compared to patients who died in the hospital, hospice patients were older, had a shorter length of stay, and experienced more comorbidities. Hospice use was more common in Medicare patients, in nonteaching hospitals, and in the South. White individuals were more likely to be discharged to hospice compared to nonwhites. Among the six selected diagnoses over the 5-year period, hospice use rose as observed mortality decreased. Our findings suggest that variability among hospitals in hospice use will affect benchmarked hospital mortality comparisons and could inappropriately reward or penalize hospitals in their public reporting.

Entities:  

Mesh:

Year:  2020        PMID: 32168186     DOI: 10.1097/JHM-D-18-00280

Source DB:  PubMed          Journal:  J Healthc Manag        ISSN: 1096-9012


  6 in total

1.  Characteristics and outcomes of patients admitted to adult intensive care units in Hong Kong: a population retrospective cohort study from 2008 to 2018.

Authors:  Lowell Ling; Chun Ming Ho; Pauline Yeung Ng; King Chung Kenny Chan; Hoi Ping Shum; Cheuk Yan Chan; Alwin Wai Tak Yeung; Wai Tat Wong; Shek Yin Au; Kit Hung Anne Leung; Jacky Ka Hing Chan; Chi Keung Ching; Oi Yan Tam; Hin Hung Tsang; Ting Liong; Kin Ip Law; Manimala Dharmangadan; Dominic So; Fu Loi Chow; Wai Ming Chan; Koon Ngai Lam; Kai Man Chan; Oi Fung Mok; Man Yee To; Sze Yuen Yau; Carmen Chan; Ella Lei; Gavin Matthew Joynt
Journal:  J Intensive Care       Date:  2021-01-06

2.  Demographic and institutional predictors of stroke hospitalization mortality among adults in the United States.

Authors:  Gabriel Neves; Travis Cole; Jeannie Lee; Tulio Bueso; Chip Shaw; Victor Montalvan
Journal:  eNeurologicalSci       Date:  2022-01-22

3.  Patient Factors Associated with Different Hospice Programs in Korea: Analyzing Healthcare Big Data.

Authors:  Young-Taek Park; Daekyun Kim; Su-Jin Koh; Yeon Sook Kim; Sang Mi Kim
Journal:  Int J Environ Res Public Health       Date:  2022-01-29       Impact factor: 3.390

4.  Sepsis-Related Mortality Rates and Trends Based on Site of Infection.

Authors:  Jonathan Prest; Thai Nguyen; Tiffany Rajah; Alayna B Prest; Matheni Sathananthan; Niranjan Jeganathan
Journal:  Crit Care Explor       Date:  2022-10-10

5.  Readmissions Reduction Program: Mortality and Readmissions for Chronic Obstructive Pulmonary Disease.

Authors:  Daniel A Puebla Neira; En Shuo Hsu; Yong-Fang Kuo; Kenneth J Ottenbacher; Gulshan Sharma
Journal:  Am J Respir Crit Care Med       Date:  2021-02-15       Impact factor: 21.405

6.  Association and risk factors of healthcare-associated infection and burden of illness among chemotherapy-induced ulcerative mucositis patients.

Authors:  P S Satheeshkumar; M P Mohan
Journal:  Clin Oral Investig       Date:  2021-08-06       Impact factor: 3.606

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.